Microbix Biosystems Inc. (MBX.TO)
CAD 0.35
(0.0%)
CAD 0.35
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 35.65 Million CAD | 7.57% |
| 2022 | 33.14 Million CAD | 14.97% |
| 2021 | 28.82 Million CAD | 84.83% |
| 2020 | 15.59 Million CAD | -20.54% |
| 2019 | 19.62 Million CAD | 1.65% |
| 2018 | 19.31 Million CAD | -26.96% |
| 2017 | 26.43 Million CAD | 4.71% |
| 2016 | 25.24 Million CAD | 7.22% |
| 2015 | 23.54 Million CAD | 30.82% |
| 2014 | 17.99 Million CAD | 41.55% |
| 2013 | 12.71 Million CAD | -5.87% |
| 2012 | 13.5 Million CAD | -2.19% |
| 2011 | 13.81 Million CAD | -3.5% |
| 2010 | 14.31 Million CAD | 1.58% |
| 2009 | 14.08 Million CAD | -3.53% |
| 2008 | 14.6 Million CAD | 151.7% |
| 2007 | 5.8 Million CAD | 46.61% |
| 2006 | 3.95 Million CAD | 0.19% |
| 2005 | 3.94 Million CAD | 17.04% |
| 2004 | 3.37 Million CAD | 13.32% |
| 2003 | 2.97 Million CAD | 9.43% |
| 2002 | 2.72 Million CAD | -8.0% |
| 2001 | 2.95 Million CAD | 1.77% |
| 2000 | 2.9 Million CAD | 7.64% |
| 1999 | 2.7 Million CAD | -67.86% |
| 1998 | 8.4 Million CAD | -7.69% |
| 1997 | 9.1 Million CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 37.92 Million CAD | 3.31% |
| 2024 Q3 | 37.73 Million CAD | -0.5% |
| 2024 Q1 | 36.7 Million CAD | 2.96% |
| 2023 FY | 35.65 Million CAD | 7.57% |
| 2023 Q1 | 32.69 Million CAD | -1.36% |
| 2023 Q2 | 33.19 Million CAD | 1.53% |
| 2023 Q4 | 35.65 Million CAD | 3.96% |
| 2023 Q3 | 34.29 Million CAD | 3.32% |
| 2022 Q1 | 31.22 Million CAD | 8.31% |
| 2022 Q4 | 33.14 Million CAD | -0.45% |
| 2022 FY | 33.14 Million CAD | 14.97% |
| 2022 Q2 | 32.94 Million CAD | 5.51% |
| 2022 Q3 | 33.29 Million CAD | 1.06% |
| 2021 Q2 | 17.95 Million CAD | 10.25% |
| 2021 Q3 | 25.86 Million CAD | 44.04% |
| 2021 Q1 | 16.28 Million CAD | 4.42% |
| 2021 FY | 28.82 Million CAD | 84.83% |
| 2021 Q4 | 28.82 Million CAD | 11.46% |
| 2020 Q4 | 15.59 Million CAD | -23.86% |
| 2020 FY | 15.59 Million CAD | -20.54% |
| 2020 Q3 | 20.48 Million CAD | -1.0% |
| 2020 Q2 | 20.69 Million CAD | 4.74% |
| 2020 Q1 | 19.75 Million CAD | 0.64% |
| 2019 FY | 19.62 Million CAD | 1.65% |
| 2019 Q1 | 19.92 Million CAD | 3.2% |
| 2019 Q2 | 20.3 Million CAD | 1.89% |
| 2019 Q4 | 19.62 Million CAD | -3.41% |
| 2019 Q3 | 20.32 Million CAD | 0.09% |
| 2018 Q2 | 26.86 Million CAD | -2.07% |
| 2018 Q4 | 19.31 Million CAD | -31.48% |
| 2018 FY | 19.31 Million CAD | -26.96% |
| 2018 Q1 | 27.43 Million CAD | 3.77% |
| 2018 Q3 | 28.17 Million CAD | 4.89% |
| 2017 FY | 26.43 Million CAD | 4.71% |
| 2017 Q4 | 26.43 Million CAD | 0.9% |
| 2017 Q3 | 26.2 Million CAD | 1.39% |
| 2017 Q2 | 25.84 Million CAD | 3.86% |
| 2017 Q1 | 24.88 Million CAD | -1.44% |
| 2016 Q4 | 25.24 Million CAD | 0.57% |
| 2016 FY | 25.24 Million CAD | 7.22% |
| 2016 Q1 | 23.53 Million CAD | -0.06% |
| 2016 Q2 | 24.15 Million CAD | 2.63% |
| 2016 Q3 | 25.1 Million CAD | 3.95% |
| 2015 Q1 | 18.84 Million CAD | 4.69% |
| 2015 Q3 | 22.23 Million CAD | 1.05% |
| 2015 Q2 | 22 Million CAD | 16.8% |
| 2015 FY | 23.54 Million CAD | 30.82% |
| 2015 Q4 | 23.54 Million CAD | 5.88% |
| 2014 Q3 | 16.01 Million CAD | 6.82% |
| 2014 Q4 | 17.99 Million CAD | 12.37% |
| 2014 Q2 | 14.99 Million CAD | 20.52% |
| 2014 FY | 17.99 Million CAD | 41.55% |
| 2014 Q1 | 12.44 Million CAD | -2.16% |
| 2013 Q4 | 12.71 Million CAD | -0.43% |
| 2013 Q1 | 12.73 Million CAD | -5.76% |
| 2013 FY | 12.71 Million CAD | -5.87% |
| 2013 Q2 | 13.01 Million CAD | 2.21% |
| 2013 Q3 | 12.77 Million CAD | -1.85% |
| 2012 Q4 | 13.5 Million CAD | 0.79% |
| 2012 FY | 13.5 Million CAD | -2.19% |
| 2012 Q3 | 13.4 Million CAD | -3.38% |
| 2012 Q2 | 13.87 Million CAD | 2.61% |
| 2012 Q1 | 13.51 Million CAD | -2.12% |
| 2011 Q1 | 13.38 Million CAD | -6.47% |
| 2011 FY | 13.81 Million CAD | -3.5% |
| 2011 Q4 | 13.81 Million CAD | -18.58% |
| 2011 Q3 | 16.96 Million CAD | -0.2% |
| 2011 Q2 | 16.99 Million CAD | 26.99% |
| 2010 FY | 14.31 Million CAD | 1.58% |
| 2010 Q4 | 14.31 Million CAD | 5.89% |
| 2010 Q2 | 14.31 Million CAD | 6.37% |
| 2010 Q3 | 13.51 Million CAD | -5.55% |
| 2010 Q1 | 13.45 Million CAD | -4.51% |
| 2009 Q3 | 13.93 Million CAD | -4.34% |
| 2009 Q4 | 14.08 Million CAD | 1.08% |
| 2009 Q1 | 14.1 Million CAD | -3.43% |
| 2009 FY | 14.08 Million CAD | -3.53% |
| 2009 Q2 | 14.56 Million CAD | 3.31% |
| 2008 Q4 | 14.6 Million CAD | 27.61% |
| 2008 Q2 | 11.54 Million CAD | -3.19% |
| 2008 Q1 | 11.92 Million CAD | 105.54% |
| 2008 FY | 14.6 Million CAD | 151.7% |
| 2008 Q3 | 11.44 Million CAD | -0.87% |
| 2007 Q4 | 5.8 Million CAD | -4.73% |
| 2007 Q1 | 3.8 Million CAD | -3.75% |
| 2007 FY | 5.8 Million CAD | 46.61% |
| 2007 Q2 | 4.02 Million CAD | 5.76% |
| 2007 Q3 | 6.09 Million CAD | 51.19% |
| 2006 FY | 3.95 Million CAD | 0.19% |
| 2006 Q4 | 3.95 Million CAD | -19.67% |
| 2006 Q3 | 4.92 Million CAD | -0.88% |
| 2006 Q2 | 4.97 Million CAD | 20.12% |
| 2006 Q1 | 4.13 Million CAD | 4.77% |
| 2005 Q4 | 3.94 Million CAD | 2.27% |
| 2005 Q3 | 3.86 Million CAD | 4.28% |
| 2005 Q2 | 3.7 Million CAD | 5.63% |
| 2005 Q1 | 3.5 Million CAD | 3.89% |
| 2005 FY | 3.94 Million CAD | 17.04% |
| 2004 Q4 | 3.37 Million CAD | 9.79% |
| 2004 FY | 3.37 Million CAD | 13.32% |
| 2004 Q1 | 2.71 Million CAD | -8.69% |
| 2004 Q2 | 3.01 Million CAD | 10.95% |
| 2004 Q3 | 3.07 Million CAD | 1.89% |
| 2003 Q2 | 2.87 Million CAD | -6.48% |
| 2003 Q4 | 2.97 Million CAD | 1.41% |
| 2003 Q3 | 2.93 Million CAD | 2.18% |
| 2003 FY | 2.97 Million CAD | 9.43% |
| 2003 Q1 | 3.07 Million CAD | 12.92% |
| 2002 Q1 | 2.74 Million CAD | -7.15% |
| 2002 FY | 2.72 Million CAD | -8.0% |
| 2002 Q2 | 2.67 Million CAD | -2.64% |
| 2002 Q3 | 2.7 Million CAD | 1.01% |
| 2002 Q4 | 2.72 Million CAD | 0.76% |
| 2001 FY | 2.95 Million CAD | 1.77% |
| 2001 Q4 | 2.95 Million CAD | -5.48% |
| 2001 Q3 | 3.12 Million CAD | 0.42% |
| 2001 Q2 | 3.11 Million CAD | 3.52% |
| 2001 Q1 | 3.01 Million CAD | 3.57% |
| 2000 Q3 | 2.9 Million CAD | 7.41% |
| 2000 Q2 | 2.7 Million CAD | 3.85% |
| 2000 Q1 | 2.6 Million CAD | -3.7% |
| 2000 FY | 2.9 Million CAD | 7.64% |
| 2000 Q4 | 2.9 Million CAD | 0.22% |
| 1999 Q1 | 7.3 Million CAD | -13.1% |
| 1999 Q3 | 6.2 Million CAD | -6.06% |
| 1999 Q2 | 6.6 Million CAD | -9.59% |
| 1999 Q4 | 2.7 Million CAD | -56.45% |
| 1999 FY | 2.7 Million CAD | -67.86% |
| 1998 Q2 | 7.7 Million CAD | -10.47% |
| 1998 Q1 | 8.6 Million CAD | -5.49% |
| 1998 FY | 8.4 Million CAD | -7.69% |
| 1998 Q4 | 8.4 Million CAD | 10.53% |
| 1998 Q3 | 7.6 Million CAD | -1.3% |
| 1997 Q2 | 2.8 Million CAD | 0.0% |
| 1997 Q3 | 9.1 Million CAD | 225.0% |
| 1997 Q4 | 9.1 Million CAD | 0.0% |
| 1997 Q1 | 2.8 Million CAD | 0.0% |
| 1997 FY | 9.1 Million CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Appili Therapeutics Inc. | 1.49 Million CAD | -2292.173% |
| Eupraxia Pharmaceuticals Inc. | 26.72 Million CAD | -33.417% |
| Helix BioPharma Corp. | 1.48 Million CAD | -2294.427% |
| Medicenna Therapeutics Corp. | 19.13 Million CAD | -86.333% |
| Satellos Bioscience Inc. | 44.29 Million CAD | 19.515% |
| Oncolytics Biotech Inc. | 38.82 Million CAD | 8.158% |
| Sernova Corp. | 22.1 Million CAD | -61.276% |